Articles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Current Editions
Search Archives
BCIQ
Company Profiles
Target Profiles
Product Profiles
Conferences
China Healthcare Summit
Bio€quity Europe
White Papers
Free Trial
/
Subscribe
Sign In
more_vert
Biocentury
Company Profiles
Target Profiles
Product Profiles
Free Trial Information
Export Pdf
Overview
Pipeline
Deals
Financings
Earnings Summary
Stock Summary
Articles
BioCentury
|
Jan 26, 2004
Company News
Neurobiological board of directors update
...Technologies Inc. (NTII), Richmond, Calif. Business: Neurology Appointed: F.
Van Kasper
, former chairman and CEO of
Van Kasper
...
Read More
BioCentury
|
Oct 20, 2003
Finance
Ebb & Flow
...conditions. The original bankers were SG Cowen; U.S. Bancorp Piper Jaffray; Dain Rauscher Wessels; and
Van Kasper
...
Read More
BioCentury
|
Dec 27, 2001
Financial News
Valentis raises $13.8 million
...the sale of 6.1 million shares at $2.251. The offering was underwritten by Wells Fargo
Van Kasper
...
Read More
BioCentury
|
Mar 26, 2001
Analyst Picks & Changes
Analyst picks & changes
...Valentis Inc. (VLTS), Burlingame, Calif. Business: Gene/Cell therapy Wells Fargo
Van Kasper
analyst Alan Auerbach began coverage...
Read More
BioCentury
|
Jan 2, 2001
Finance
Ebb & Flow
...will be underwritten by SG Cowen; U.S. Bancorp Piper Jaffray; Dain Rauscher; and First Security
Van Kasper
...
Read More
BioCentury
|
Dec 22, 2000
Financial News
Xcyte files for IPO
...will be underwritten by SG Cowen; U.S. Bancorp Piper Jaffray; Dain Rauscher; and First Security
Van Kasper
. BC...
Read More
BioCentury
|
Aug 14, 2000
Analyst Picks & Changes
Analyst picks & changes
...Dura Pharmaceuticals Inc. (DURA), San Diego, Calif. Business: Drug delivery, Pulmonary First Security
Van Kasper
analyst Bud...
Read More
BioCentury
|
Aug 14, 2000
Analyst Picks & Changes
Analyst picks & changes
...Epoch Biosciences Inc. (EBIO), Redmond, Wash. Business: Enabling technology First Security
Van Kasper
analyst Alan Auerbach began...
Read More
BioCentury
|
Aug 14, 2000
Finance
Some warning signs
...through the sale of 2.4 million shares at $6. The deal, underwritten by First Securities
Van Kasper
...
Read More
BioCentury
|
Aug 8, 2000
Financial News
Immune Response raises $14.4 million
...in a follow-on through the sale of 2.4 million shares at $6. Underwriters First Security
Van Kasper
...
Read More
Items per page:
10
1 - 10 of 28
BioCentury
|
Jan 26, 2004
Company News
Neurobiological board of directors update
...Technologies Inc. (NTII), Richmond, Calif. Business: Neurology Appointed: F.
Van Kasper
, former chairman and CEO of
Van Kasper
...
Read More
BioCentury
|
Oct 20, 2003
Finance
Ebb & Flow
...conditions. The original bankers were SG Cowen; U.S. Bancorp Piper Jaffray; Dain Rauscher Wessels; and
Van Kasper
...
Read More
BioCentury
|
Dec 27, 2001
Financial News
Valentis raises $13.8 million
...the sale of 6.1 million shares at $2.251. The offering was underwritten by Wells Fargo
Van Kasper
...
Read More
BioCentury
|
Mar 26, 2001
Analyst Picks & Changes
Analyst picks & changes
...Valentis Inc. (VLTS), Burlingame, Calif. Business: Gene/Cell therapy Wells Fargo
Van Kasper
analyst Alan Auerbach began coverage...
Read More
BioCentury
|
Jan 2, 2001
Finance
Ebb & Flow
...will be underwritten by SG Cowen; U.S. Bancorp Piper Jaffray; Dain Rauscher; and First Security
Van Kasper
...
Read More
BioCentury
|
Dec 22, 2000
Financial News
Xcyte files for IPO
...will be underwritten by SG Cowen; U.S. Bancorp Piper Jaffray; Dain Rauscher; and First Security
Van Kasper
. BC...
Read More
BioCentury
|
Aug 14, 2000
Analyst Picks & Changes
Analyst picks & changes
...Dura Pharmaceuticals Inc. (DURA), San Diego, Calif. Business: Drug delivery, Pulmonary First Security
Van Kasper
analyst Bud...
Read More
BioCentury
|
Aug 14, 2000
Analyst Picks & Changes
Analyst picks & changes
...Epoch Biosciences Inc. (EBIO), Redmond, Wash. Business: Enabling technology First Security
Van Kasper
analyst Alan Auerbach began...
Read More
BioCentury
|
Aug 14, 2000
Finance
Some warning signs
...through the sale of 2.4 million shares at $6. The deal, underwritten by First Securities
Van Kasper
...
Read More
BioCentury
|
Aug 8, 2000
Financial News
Immune Response raises $14.4 million
...in a follow-on through the sale of 2.4 million shares at $6. Underwriters First Security
Van Kasper
...
Read More
Items per page:
10
1 - 10 of 28
Previous page
Next page